Viewing Study NCT03301350


Ignite Creation Date: 2025-12-24 @ 5:23 PM
Ignite Modification Date: 2026-02-02 @ 2:28 AM
Study NCT ID: NCT03301350
Status: COMPLETED
Last Update Posted: 2023-02-01
First Post: 2017-09-29
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer
Sponsor: University of Wisconsin, Madison
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Triple Negative Breast Cancer View
Keywords: